15.01.2013 - AstraZeneca's new chief executive stamped his authority on the struggling drugmaker on Tuesday by removing the heads of research and commercial operations. Pascal Soriot, who took...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
